  |
 |
Robert Freedman, M.D.
Genetics of schizophrenia; a7-nicotonic
receptor
Dr. Freedman's laboratory is concerned with understanding the development
of schizophrenia. Using psychophysiological tools such as auditory evoked
potentials with schizophrenics and their families, his laboratory identifies
individuals who may carry genes which convey risk for schizophrenia. Molecular
biological tools such as gene sequencing and in situ hybridization are
used to search for the genetic abnormalities in schizophrenia. Facilities
range from a laboratory nursery school, where one can observe the development
of children of schizophrenic mothers, to basic science laboratories, where
psychophysiological abnormalities can be modeled in animals and studied
at the single neuron level. The fellowship is an opportunity for clinically
trained fellows to learn the application of neurobiological and molecular
biological techniques to psychopathological problems and for those with
basic science background to learn to work with human materials.
Publications
Ross RG, Olincy A, Harris JG, Radant A, Hawkins M, Adler LE, Freedman
R. Evidence for bilineal inheritance of physiological indicators of risk
in childhood-onset schizophrenia. American Journal of Medical Genetics:
Neuropsychiatric Genetics, 88, 188-199, 1999.
Freedman R, Adams C, Leonard S. The alpha7-nicotinic acetylcholine receptor
and the pathology of hippocampal interneurons in schizophrenia. J. Chem.
Neuroanatomy 20:295-306, 2000.
Olincy, A, Ross, RG., Harris, JG., Young, DA., McAndrews, MA, Cawthra,
E., McRae, KA., Sullivan, B., Adler, LE, Freedman RF. The P50 Auditory
Event-Evoked Potential in Adult Attention-Deficit Disorder: Comparison
with Schizophrenia. Biol. Psych. 47:969-977, 2000.
Adams, C.E., Stevens, K.E., Kem. W.R., Freedman, R. Inhibition of nitric
oxide synthase prevents a7 nicotinic receptor-mediated restoration of
inhibitory auditory gating in rat hippocampus. Brain Research, 877:235-244,
2000.
Simosky, J.K., Stevens, K.E., Kem, W.R., Freedman, R. Intragastric DMXB-A,
an ?7 nicotinic agonist, improves deficient sensory inhibition in DB/2
mice. Biol. Psychiatry 50(7): 493-500, 2001.
Kisley, M.A., Olincy, A., Freedman, R. The effect of state on sensory
gating: comparison of waking, REM and non-REM sleep. Clinical Neurophysiology
112:1154-1165, 2001.
Freedman R and Leonard S. Genetic linkage to schizophrenia at chromosome
15q14. Am. J. Med. Gen., Neuropsych. Gen., 105:655-657,2001.
Adams CE, Stitzel JA, Collins AC, Freedman R. alpha7-Nicotinic receptor
expression and the anatomical organization of hippocampal interneurons.
Brain Res 20;922(2):180-190, 2001.
Freedman R, Leonard S, Olincy A, Kaufmann, CA, Malaspina D, Cloninger
CR, Svrakic D, Faraone SV, and Tsuang M. Evidence for the multigenic inheritance
of schizophrenia. American J of Medical Genetics 105:794-800, 2001.
Freedman, R. Electrophysiological Phenotypes. Psychiatric Genetics, Humana
Press. 9:211-221, 2002.
Tanabe,J., Miller,D., Tregellas,J., Freedman,R., and Meyer,F.G.. Comparison
of Detrending Methods for Optimal fMRI Preprocessing. Neuroimage. 15,
902-907,2002.
Simosky JK, Stevens KE, Freedman R. Nicotinic Agonists in Psychosis. Current
Drug Targets: CNS and Neurological Disorders, 1 (2): 149-162, 2002.
Freedman, R. Long-term effects of early genetic influences on behavior.
New England Journal of Medicine. 347(3):213-215-2002.
Harris, JG, Young, DA, Rojas, DC, Cajade-Law A., Scherzinger. A., Nawroz,
S., Adler, LE, Cullum, CM, Simon J. and Freedman, R. Increased hippocampal
volume in schizophrenics’ parents with ancestral history of schizophrenia.
Schizophrenia Research. 55(1-2):11-17,2002.
Freedman, R., Adler, LE, Olincy, A., Waldo, MC, Ross, RG, Stevens, KE.,
Leonard, S. Input dysfunction, schizotypy, and genetic models of schizophrenia.
Schizophrenia Research. 54(1-2)25-32, 2002.
Tanabe J, Tregellas J, Miller D, Ross R. Freedman R. Brain activation
during smooth pursuit eye movements. Neuroimage 17:1315-1234, 2002.
Simosky,J.K., Stevens,K.E., Adler,L.E., and Freedman,R. Clozapine improves
deficient inhibitory auditory processing in DBA/2 mice via a nicotinic
cholinergic mechanism. Psychopharmacology 165:386-396, 2003.
Ross,R.G., Olincy,A., Mikulich,S.K., Radant,A.D., Harris,J.G., Waldo,M.,
Compagnon,N., Heinlein,S., Leonard,S., Zerbe,G.O., Adler,L., and Freedman,R.
Admixture analysis of smooth pursuit eye movements in probands with schizophrenia
and their relatives suggests gain and leading saccades are potential endophenotypes.
Psychophysiology, 39:809-819, 2002.
Leonard,S., Gault,J., Hopkins,J., Logel,J., Drebing,C., Vianzon,R., Short,M.,
Berger,R., Robinson,M., and Freedman,R. Promoter variants in the a7 nicotinic
acetylcholine receptor subunit gene are assoicated with an inhibitory
deficit found in schizophrenia. Arch Gen Psychiatry 59:1085-1096, 2002.
Adams CE, Broide RS, Chen Y, Winzer-Serhan UH, Henderson TA, Leslie FM,
Freedman R. Development of the ?7 nicotinic receptor in rat hippocampal
formation. Developmental Brain Res 139:175-187, 2002.
Leonard S and Freedman R. Recombination in an NIMH Schizophrenia Genetics
Initiative Family Fails to Exclude the 15q14 CHRNA7 Locus. Molecular Psychiatry
8:145-146, 2003.
Kisley,M.A., Olincy,A., Robbins,E., Polk,S.D., Adler,L.E., Waldo,M.C.,
and Freedman,R. (2002). Sensory gating impairment associated with schizophrenia
persists into REM sleep. Psychophysiology, 4); 29-38., 2003.
Kisley MA. Polk SD. Ross RG. Levisohn PM. Freedman R. Early postnatal
development of sensory gating. Neuroreport. 14:693-7, 2003.
Tregellas JR, Jody L. Tanabe, David E. Miller, Randal G. Ross, Ann Olincy,
Robert Freedman. Neurobiology of Smooth Pursuit Eye Movement Deficits
in Schizophrenia: An fMRI Study. American J of Psychiatry, in press.
Gault,J., Hopkins,J., Berger,R., Drebing,C., Logel,J., Walton,K., Short,M.,
Vianzon,R., Olincy,A., Ross,R.G., Adler,L.E., Freedman,R. and Leonard,S.
(2003). Comparison of polymorphisms in the a7 nicotinic receptor gene
and its partial duplication in schizophrenic and control subjects. Neuropsychiatric
Genetics, in press.
Freedman, R. Current Drug Therapy: Schizophrenia. New England Journal
of Medicine, in press.
|